跳至主要内容
临床试验/NCT03933748
NCT03933748招募中不适用

Therapeutic Drug Monitoring of Teicoplanin in Children

Shandong University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2019年4月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
Plasma drug concentration

研究概览

简要总结

In this study, the therapeutic drug monitoring of teicoplanin is carried out among children to obtain the drug concentration, clinical efficacy and safety data of children patients in different gender and age groups. Then we analyze the relationship between blood drug concentration and efficacy and safety, and provide recommendations for the treatment window of teicoplanin in Chinese children.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Teicoplanin was administered intravenously;
  • Teicoplanin was used for therapeutic purposes;
  • Age:≤18 years;
  • Clinician confirms and plans to diagnose the patient with gram-positive coccus infection;
  • Patients with therapeutic concentration monitoring of teicoplanin.

排除标准

  • Teicoplanin was administered non-intravenously;
  • Teicoplanin was used for prophylactic purposes;
  • Patients without therapeutic concentration monitoring of teicoplanin;
  • Patients who die within 24 hours of the use of teicoplanin;
  • The blood concentrations of the patient was not approved by the quality control center.

结局指标

主要结局

Plasma drug concentration

时间窗: Through study completion, an average of 14 days

To detect the plasma concentrations of teicoplanin at therapeutic drug monitoring (TDM).

次要结局

未报告次要终点

研究者

发起方
Shandong University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wei Zhao

Head of department of clinical pharmacy and pharmacology

Shandong University

研究点 (1)

Loading locations...

相似试验